A Missouri-based gender clinic that’s faced government scrutiny this year was the subject of a recent New York Times article looking into a whistleblower’s claims that providers were too quick to administer hormone drugs to minor patients without requiring those children to undergo therapy amid rising demand in recent years.
The Christian Post | RSS